DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...

U.K.-based SkyePharma's Flutiform, an inhaled combination of fluticasone and formoterol, has been launched in Germany by the company's partner, Mundipharma, as an asthma maintenance therapy.

Regulatory filing in Europe is expected during the first quarter of 2010. SkyePharma and Mundipharma have reported positive results from a Phase III trial with the inhaled asthma drug combination, ...

LONDON, March 23 (Reuters) - SkyePharma Plc has submitted its asthma drug Flutiform for approval with the U.S. Food and Drug Administration, bringing the medicine's commercialisation a step nearer.

LONDON (Reuters) - Drug delivery specialist SkyePharma said it was in the process of filing its Flutiform asthma drug for European approval, following recent setbacks in the United States. SkyePharma ...